Loading...
Please wait, while we are loading the content...
Similar Documents
Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Curtis, L. D. Dickson, Andrew C. Ling, Khoon Lin Betteridge, John |
| Copyright Year | 1988 |
| Abstract | Cholestyramine and bezafibrate were compared individually and in combination in the treatment of 18 patients with heterozygous familial hypercholesterolaemia. The study used a double blind, placebo controlled block design with a placebo run in period of two months followed by three phases of active treatment, each of two months' duration. Patients were randomly allocated to one of the six possible sequences of medication so that three patients would be treated with each sequence. Two patients withdrew from the study before completion. The median concentration of total cholesterol decreased from 9.65 mmol/l (interquartile range 8.62 to 8.72) to 7.24 mmol/l (6.70 to 7.52) with cholestyramine, to 8.09 mmol/l (7.18 to 8.68) with bezafibrate, and to 6.31 mmol/l (5.84 to 7.27) with the combination. This fall was due almost entirely to a decrease in the low density lipoprotein cholesterol concentration, and the combination was significantly more effective than either drug alone. The 98% confidence intervals for the median differences between the combination and cholestyramine and the combination and bezafibrate were 0.04 to 1.49 mmol/l and 0.51 to 2.18 mmol/l respectively. These results suggest that this combination is an effective and useful treatment in heterozygous familial hypercholesterolaemia. |
| Starting Page | 159 |
| Ending Page | 163 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.bmj.com/content/bmj/297/6642/173.full.pdf |
| PubMed reference number | 3044508v1 |
| Volume Number | 297 |
| Issue Number | 6642 |
| Journal | BMJ |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Bezafibrate Cholestyramine Resin Confidence Intervals DNA Breaks, Double-Stranded Hypercholesterolemia Hypercholesterolemia, Familial Interquartile Range LDL Cholesterol Lipoproteins Millimole per Liter Patients |
| Content Type | Text |
| Resource Type | Article |
